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Objective: To assess the accuracy of chest radiography (CXR) in predicting pulmonary hypertension (PH).
Methods:We studied 108 consecutive patients with suspected PH who underwent right heart catheterization (RHC).
All were PH treatment naives. Hemodynamic criteria included a mean pulmonary artery pressure N25 mmHg
at rest, and a mean pulmonary wedge pressure b15 mmHg. Postero-anterior and lateral CXR were obtained
shortly before RHC. To avoid a selection bias which could be introduced by examining only patients with
suspected PH, we included in the analysis the CXR of 454 additional patients with different diagnosis: 57 with
left heart failure (LHF) and pulmonary venous hypertension at RHC, 197 with chronic obstructive pulmonary
disease, and 200 non-obstructed controls. CXR were examined independently by 4 raters, who were blinded
to clinical, hemodynamic, and spirometric data. The diagnosis of PH was made if a prominent main pulmonary artery
was associatedwith anyone of: isolated enlargement of right ventricle, right descending pulmonary artery N16 mm in
diameter, pruning of peripheral pulmonary vessels.
Results: Eighty-two patients had PH confirmed at RHC. Weighted sensitivity of CXR was 96.9% (95% confidence
interval, 94.9 to 98.2%), and weighted specificity 99.8% (95% confidence interval, 99.6 to 99.9%). By considering
the 165 patients who underwent RHC, weighted sensitivity of CXR was unchanged, and weighted specificity
decreased to 99.1%. None of the patients with PH were misclassified as having LHF, and vice versa.
Conclusions: CXR is accurate in predicting PH. It may aid clinicians in selecting patients with suspected PH for
hemodynamic ascertainment.
© 2013 Elsevier Ltd. All rights reserved.
Introduction
Pulmonary hypertension (PH), in its “pre-capillary” form, is a rare
but devastating disorder that carries high morbidity, and mortality
[1,2]. Clinical symptoms and signs are nonspecific, and the definitive
diagnosis rests on the hemodynamic documentation of a mean pulmo-
nary artery pressure exceeding 25 mmHg at rest with a normal pulmo-
nary artery wedge pressure [1,2].
The suspicion of the disease is often raised by the incidental finding
of elevated pulmonary artery systolic pressure at Doppler echocardiog-
raphy (DE). Even though DE is a valuable screening method, estimates
of pulmonary artery pressure are frequently inaccurate [3,4].
Chest radiography is still ubiquitous in clinical practice, and will
likely remain so for quite some time for it is inexpensive andminimally
invasive in terms of radiation exposure [5]. The radiologic abnormalities
associated with PH have been described [6–10], but very few studies
investigated on the predictive accuracy of chest radiography [11–13].
The present study was designed to assess the sensitivity and spec-
ificity of chest radiography in the diagnosis of pre-capillary PH. We
examined postero-anterior and lateral chest radiographs of 108 con-
secutive patients with clinically suspected PH who underwent right
heart catheterization (RHC). To avoid a selection bias, we included in
the analysis the chest radiographs of 454 additional individuals: 57
with chronic left heart failure and pulmonary venous hypertension,
197 with chronic obstructive pulmonary disease, and 200 with normal
lung function.
Materials and Methods
Ethics Statement
The study was carried out in accordance with The Code of Ethics of
the World Medical Association (Declaration of Helsinki), and was
approved by the institutional review board (Comitato Etico, Azienda
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Ospedaliero Universitaria Pisana). Before entering the study, the pa-
tients provided an informed written consent.
Sample
The sample comprised 108 consecutive patients with suspected PH,
who were referred to the CNR Institute of Clinical Physiology and
Tuscany Foundation “G. Monasterio”, Pisa, Italy, between January 1,
2006 andDecember 31, 2011. The above institutions serve as referral cen-
ter for the diagnosis and treatment of PH. The suspicion of the disease had
been raised by the referring physicians on the basis of relevant presenting
symptoms (primarily unexplained dyspnea on exertion), risk factor as-
sessment, or elevated pulmonary artery systolic pressure at DE. None of
the patients was receiving any medication for PH at the time of study
entry.
To avoid a selection biaswhich could be introducedby examiningonly
the chest radiographs of patients with suspected PH, we included in the
analysis the chest radiographs of 454 additional subjects from twodistinct
groups.
The first consisted of 57 patients with left heart failure (LHF) who
were evaluated at the above institutions between January 1, 2002 andDe-
cember 31, 2008. The diagnosis of LHF was based on the Framingham
criteria [14], and the finding of a left ventricular ejection fraction ≤40%
at echocardiography. The 57 patients underwent RHC as part of their clin-
ical evaluation.
The second group included 397 subjects ofwhom197 had chronic ob-
structive pulmonary disease (COPD), and 200 were non-obstructed con-
trols. They were evaluated at the CNR Institute of Clinical Physiology
from November 1, 2001 through October 31, 2003 as part of a larger
cohort enrolled in a European case-control study aimed at assessing
genetic susceptibility to the development of COPD [15]. The criteria for
case recruitment were: (a) firm clinical diagnosis of stable COPD; (b) air-
flow obstruction as indicated by a post-bronchodilator ratio of forced ex-
piratory volume in one second over forced vital capacity (FEV1/FVC) b0.7
and FEV1 ≤70% of the predicted value; (c) smoking history ≥20 pack-
years. Patients were excluded if they had a diagnosis of asthma, chronic
lung disorders other than COPD, active lung cancer, or if they had had a
clinically confirmed acute exacerbation in the 4 weeks preceding the
study entry. By design, the controlswere recruited tomatch the COPDpa-
tients on age, gender, and smoking history. The criteria for control recruit-
ment were: (a) FEV1/FVC ratio N0.7; (b) both FVC and FEV1 N80% of
predicted value; (c) no history of chronic lung disease, and no acute respi-
ratory infection in the 4 weeks preceding the study entry. Postero-
anterior and lateral chest radiographs were taken on the day of recruit-
ment. The 397 individuals were followed up for a median time of
9.9 years (interquartile range, 8.6 to 10.7 years), and none of themdevel-
oped PH. This comes of no surprise given that PH is a very rare disorder.
Study Protocol
Right Heart Catheterization
RHC was performed by experienced physicians (BF, CM) with the
patient at rest and without sedation. End-expiratory pressure measure-
ments were taken at the level of the right atrium, right ventricle, and
pulmonary artery over at least five cardiac cycles. Cardiac output was
measured in triplicate by the thermodilution method, and the average
value calculated. PH was diagnosed if the mean pulmonary artery
pressure (MPAP) at rest was N25 mmHg, and the mean pulmonary
wedge pressure (MPWP) b15 mmHg [1,2]. Oxymetry was used to
detect left-to-right shunting.
Chest Radiography
Postero-anterior and lateral digital chest radiographs were obtained
at a standard 2-m focus-to-detector distance with the patients upright,
Table 1
Reading table for chest radiographs.
1. Heart
Prominence of the main pulmonary artery
Yes
No
Enlargement of the right ventricle
Yes
No
Enlargement of the left ventricle
Yes
No
2. Pulmonary vessels
Right descending pulmonary artery N16 mm in diameter
Yes
No
Pruning of the peripheral vessels
Yes
No
Dilated upper lobe vessels
Yes
No
3. Lung parenchyma and pleura
Interstitial edema
Yes
No
Emphysema
Yes
No
Fibrosis
Yes
No
Pleural effusion
Yes
No
Table 2
Baseline characteristics of 108 patients with suspected pulmonary hypertension.
Characteristic PH (n = 82) No PH (n = 26)
Age, years 66 (57-74) 72 (68-75)
Male sex 32 (39) 9 (35)
MRAP, mmHg 4 (2-7) 2 (2-4)
MPAP, mmHg 41 (33-49) 17 (13-21)
MPWP, mmHg 6 (4-9) 6 (5-8)
CI, L/min/m2 2.6 (2.2-3.1) 3.0 (2.6-3.5)
PVR, mmHg/L/min/m2 12.5 (9.6-16.2) 3.1 (2.3-4.4)
Data are numbers (%), or medians (interquartile range).
PH = pulmonary hypertension (pre-capillary).
MRAP = mean right atrial pressure.
MPAP = mean pulmonary artery pressure.
MPWP = mean pulmonary wedge pressure.
CI = cardiac index (cardiac output/body surface area).
PVR = pulmonary vascular resistance = MPAP-MPWP/CI.
Table 3
Baseline characteristics of 57 patients with left heart failure.
Age, years 67 (57-73)
Male sex 43 (75)
COPD comorbidity 17 (30)
MRAP, mmHg 7 (5-10)
MPAP, mmHg 33 (31-40)
MPWP, mmHg 20 (18-23)
CI, L/min/m2 2.4 (2.0-2.9)
PVR, mmHg/L/min/m2 5.8 (4.3-7.9)
Data are numbers (%), or medians (interquartile range).
COPD = chronic obstructive pulmonary disease.
For other abbreviations, see Table 2.
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holding their breath at full inspiration (Thorax 2000, IMIX, Finland).
Kilovoltage and tube current were adjusted to the patient’s body
build. In patients who underwent RHC, chest radiographs were taken
within 24 hours prior to the hemodynamic study. All the chest
radiographs were saved in DICOM format, had the identification data
removed, and were given a random code prior to be examined on a
workstation equipped with a DICOM viewer (OsiriX 64-bit).
Analysis of Chest Radiographs
Two board certified chest physicians (MM, SM), and two residents in
respiratorymedicine (EA, RP) examined independently the chest radio-
graphs using a standardized reading table (Table 1). All the raters were
blinded to clinical, echocardiographic, hemodynamic, and spirometric
data. Two raters had long experience in interpreting chest radiographs,
whereas the others had less than 5-year experience. The criteria used to
identify the radiologic abnormalities of Table 1 are described in full in
the Appendix A. The radiologic diagnosis of PH was established when-
ever a prominent main pulmonary artery was associated with at least
one of the following abnormalities: (a) isolated enlargement of the
right ventricle; (b) right descending pulmonary artery greater than
16 mm in diameter [16]; (c) pruning of peripheral pulmonary vessels.
Isolated prominence of the main pulmonary artery was deemed
insufficient to rule in a diagnosis of PH for two reasons: (a) slight
prominence of this vessel may occasionally be seen in young and other-
wise healthy subjects, especially female; (b) aneurysmatic dilatation of
the main pulmonary artery has been sporadically reported in adults
with normal pulmonary artery pressure [17]. The width of the main
pulmonary artery was estimated in the frontal chest radiograph, and
was plotted against MPAP measured at RHC in 165 patients [18–20].
Details are given in the Appendix A.
Statistical Analysis
Differences between groups were assessed by Fisher’s exact test for
the categorical variables, and by Mood’s median test for the continuous
variables. Continuous variables in the text and in the tables are reported
as medians and interquartile range (IQR). Inter-rater agreement was
assessed with the kappa statistics [21]. Weighted sensitivity was
calculated by taking the ratio of the total number of true positives to
the sum of true positive and false negative ratings. Weighted specificity
was calculated by taking the ratio of the total number of true negatives
Table 4
Characteristics of 397 subjects with and without COPD.
Characteristic COPD (n = 197) No COPD (n = 200)
Age, years 66 (61-70) 65 (61-70)
Male sex 176 (89) 172 (86)
Current smokers 96 (49) 101 (50)
Left heart failure⁎ 26 (13) 18 (9)
Coronary artery disease 59 (30) 55 (28)
Systemic arterial hypertension 94 (48) 75 (38)
FEV1, % predicted 54 (42-65) 95 (88-105)
DLCO, % predicted 76 (58-86) 96 (86-108)
Data are numbers (%), or medians (interquartile range).
COPD = chronic obstructive pulmonary disease.
FEV1 = forced expiratory volume in one second.
DLCO = diffusing capacity of the lung for carbon monoxide.
⁎ Left ventricular ejection fraction ≤40% at transthoracic echocardiography.
Table 5
Chest radiography in diagnosing pulmonary hypertension.
PH at RHC (n = 82) No PH (n = 480) No PH at RHC (n = 83)⁎
Rater True positive % True negative % True negative %
MM 81 98.8 480 100 83 100
SM 80 97.6 480 100 83 100
EA 79 96.3 479 99.8 82 98.8
RP 78 95.1 478 99.6 81 97.6
PH = pulmonary hypertension (pre-capillary).
RHC = right heart catheterization.
⁎ 26 with normal pulmonary artery pressures, and 57 with pulmonary venous hypertension due to chronic left heart failure.
Fig. 1.Weighted prevalence of chest radiographic abnormalities in 82 patients with
pre-capillary pulmonary hypertension (PH) and 57 with left heart failure (LHF) and
pulmonary venous hypertension at right heart catheterization. MPA = main
pulmonary artery; RV = right ventricle; LV = left ventricle; RDPA = right descending
pulmonary artery; UL = upper lobe.
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to the sum of true negative and false positive ratings. Positive predictive
value was defined as the proportion of patients with confirmed pre-
capillary PH at RHC among those classified as having the disease; nega-
tive predictive value as the proportion of patients without pre-capillary
PH among those classified as not having the disease. Two-tailed p-values
b0.05 were considered statistically significant throughout. Bayes’ theo-
rem was used to calculate the probability of PH conditioned by the
results of chest radiography (post-test probability) as a function of
pre-test (clinical) probability [22]. For the analysis, we utilized Stata
version 11 (StataCorp, College Station, TX).
Results
Sample
Of the 108 patients who underwent RHC for suspected PH, 82 had
the diagnosis confirmed (Table 2). PHwas idiopathic in 22 cases, associ-
ated with connective tissue disease in 18, with chronic lung disease in
14, and chronic thromboembolic in 26. In one patient, PH developed
in the wake of congenital heart disease with left-to-right shunt; in
another, it was associated with lymphangioleiomyomatosis.
According to theWorld Health Organization (WHO) clinical classifi-
cation [23], the 82 patients were as follows: Group 1 (pulmonary arteri-
al hypertension), n = 41; Group 3 (pulmonary hypertension due to
lung diseases and/or hypoxia) n = 14; Group 4 (chronic thromboembolic
pulmonary hypertension), n = 26; Group 5 (pulmonary hypertension
with unclear and/or multifactorial mechanisms), n = 1.
Patients with idiopathic PH had amedian age of 45 years (IQR, 37 to
61 years), and were significantly younger (p b 0.001) than those with
other forms of PH (median age 70 years; IQR, 63 to 75 years). Among
the 26 patients without PH at RHC, 15 had connective tissue disease,
5 coronary artery disease, and 6 COPD.
The baseline characteristics and hemodynamic data of the 57
patients with LHF (Group 2 of the WHO clinical classification) are
given in Table 3. The characteristics of the 397 additional subjects (197
with COPD and 200 non-obstructed controls) are reported in Table 4.
Chest Radiography
Table 5 describes the sensitivity and specificity of chest radiography
attained by the 4 raters upon examining the chest radiographs of 562
individuals. The weighted sensitivity for pre-capillary PH was 96.9%,
(95% CI, 94.9 to 98.2%), and the weighted specificity 99.8% (95% CI,
99.6 to 99.9%). The positive predictive value was 99.1% (95% CI, 97.3 to
99.7%), and the negative predictive value 99.5% (95% CI, 99.0 to 99.7%).
By considering only the 165 patients who underwent RHC, the
weighted sensitivity remained unchanged and the weighted specificity
decreased to 99.1% (95% CI, 97.2 to 99.8%). The positive predictive value
Fig. 2. Chest radiographs of a 38-year-old femalewith idiopathic pulmonary hypertension.Mean pulmonary artery pressure is 63 mmHg, andmean pulmonarywedge pressure 5 mmHg.
(A) Postero-anterior view: arrowheads indicate prominent main pulmonary artery and enlarged right descending pulmonary artery. Pruning of peripheral vessels is evident. (B) Lateral
view: arrowheads indicate increased area of contact between heart and anterior chest wall consistent with enlargement of right ventricle.
Fig. 3.Chest radiographs of a 57-year-oldmalewith left heart failure.Mean pulmonary artery pressure is 50 mmHg, andmean pulmonarywedge pressure 28 mmHg. (A) Postero-anterior
view: arrowhead indicates enlargement of left ventricle. Arrows indicate dilated arteries and veins in upper lung regions. Interstitial edema is manifested by blurred vessel margins and
peribronchial cuffs. (B) Lateral view: arrowhead indicates enlargement of left ventricle. Arrows indicate dilated arteries and veins in upper lung regions. Blurring of hilar vessels is evident.
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was unchanged, and the negative predictive value decreased to 97.0%
(95% CI, 94.7 to 98.4%).
Most of the patients with established pre-capillary PH had 3 or all 4
of the radiographic criteriawe used for the diagnosis (see online supple-
ment for details).
Six patients with PH were rated as negative by at least one rater.
MPAP measured at RHC was 26, 27, 27, 32, 34, and 35 mmHg, respec-
tively. Four of these patients had lung fibrosis. Two of the 26 patients
without PH were judged as positive by at least one rater. One patient
had a MPAP of 16 mmHg, and a MPWP of 3 mmHg. In the other, who
had radiologic evidence of lung fibrosis, MPAP was 18 mmHg and
MPWP 6 mmHg. None of the patients with PH were misclassified as
having LHF, and vice versa.
Fig. 1 shows the prevalence of radiographic abnormalities in 82
patients with PH and in 57 with LHF and pulmonary venous hyperten-
sion. Prominence of the main pulmonary artery, enlargement of the
right ventricle, and pruning of pulmonary vessels prevailed significantly
in patients with PH with respect to those having LHF (p b 0.0001). By
contrast, enlarged left ventricle, dilated upper lobe vessels, interstitial
edema, and pleural effusion were the distinctive features of patients
with LHF and pulmonary venous hypertension (p b 0.0001). A ra-
diographic example of PH is given in Figs. 2, whereas Fig. 3 shows
the chest radiographs of a patient with LHF and pulmonary venous
hypertension.
The radiographic findings in 197 patients with COPD and 200 non-
obstructed controls are reported in Table 6. A prominent main pul-
monary artery was observed in only one patient with COPD who had
severe airflow obstruction (FEV1 35 % predicted), and chronic ischemic
cardiomyopathy (left ventricular ejection fraction 30%). His chest ra-
diographs showed dilated left ventricle, dilated upper lobe vessels,
and mild interstitial edema.
Inter-rater Agreement
Inter-rater agreement in diagnosing or excluding PH was excellent
(kappa 0.96, 95% CI, 0.93 to 1.00). Similarly, there was nearly perfect
agreement in identifying most of the radiologic abnormalities included
in the analysis (Table 7). Agreement was somewhat lower in assessing
pruning of peripheral pulmonary vessels, dilated upper lobe vessels,
and interstitial edema. This is expected because the identification of
such abnormalities requires substantial expertise.
Relationship Between Pre-test and Post-test Probability of PH
Fig. 4 displays the relationship between pre-test (clinical) and post-
test probability of PH conditioned by the results of chest radiography. In
constructing the graph, we assumed pre-test probability as based on
clinical symptoms and signs only. At a pre-test probability of 50%, the
post-test probability is 98% if the chest radiograph is positive, but only
3% if the radiograph is negative.
Width of Main Pulmonary Artery Against MPAP
Fig. 5 shows the scatter plot of the main pulmonary artery width, as
percentage of thewidth of the left hemithorax, against MPAPmeasured
at RHC in 82 patients with PH (left panel), and 57 with LHF and pul-
monary venous hypertension (right panel). Data from 26 patients
with normal pulmonary artery pressure are displayed for comparison.
The relationship is curvilinear and is best fitted by an exponential func-
tion (p b 0.0001).
Discussion
The radiologic assessment of suspected PH begins with the evalua-
tion of the shape of the main pulmonary artery. In normal adults, this
vascular segment casts a straight, or slightly concave shadow in be-
tween the aortic knob and the left atrial appendage. Dilatation of the
main pulmonary artery is manifested on the frontal chest radiograph
by a convex shadow bulging out along the left cardiac border (Fig. 2).
We felt inappropriate to rule in a radiologic diagnosis of PH only on
the basis of a prominent main pulmonary artery, and we required the
coexistence of at least one of three abnormalities that are known to
occur in such disease [6–10].
By adopting these criteria, chest radiography yielded high diagnostic
accuracy for PH. The false negative cases had mild elevation of pulmo-
nary artery pressure, and often featured coexisting lung fibrosis. None
of the patients with LHF and pulmonary venous hypertension were
misclassified as having PH and vice versa.
Our findings may have practical implications. As shown in Fig. 4,
chest radiography can be used to predict the post-test probability of
PH as a function of the pre-test (clinical) probability. If the latter is, say,
50%—as it is often the case, given the non-specificity of the presenting
symptoms and signs—the simple taking of the chest radiograph may
aid clinicians in decision making.
A chest radiograph strongly suggestive of PH makes the diagnosis
very likely and should prompt confirmatory tests, including RHC. In
Table 6
Radiographic findings in 397 subjects with and without COPD.
Finding COPD (n = 197) No COPD (n = 200)
Prominent main pulmonary artery 1 (0.5) 0 (0)
Enlarged right ventricle 42 (21) 1 (0.5)
Enlarged left ventricle 60 (30) 57 (29)
RDPA N16 mm in diameter 103 (52) 47 (24)
Pruning of peripheral vessels 0 (0) 0 (0)
Dilated upper lobe vessels 25 (13) 15 (7.5)
Interstistial edema 1 (0.5) 0 (0)
Emphysema 80 (41) 0 (0)
Fibrosis 0 (0) 0 (0)
Pleural effusion 5 (2.5) 0 (0)
Data are numbers (%).
COPD = chronic obstructive pulmonary disease.
RDPA = right descending pulmonary artery.
Table 7
Inter-rater agreement in reading chest radiographs.
Radiographic finding kappa (95% CI)
Prominent main pulmonary artery 0.93 (0.90-0.96)
Enlarged right ventricle 0.94 (0.91-0.97)
Enlarged left ventricle 0.99 (0.95-1.00)
Right descending pulmonary artery N16 mm 0.99 (0.95-1.00)
Pruning of peripheral vessels 0.80 (0.77-0.83)
Dilated upper lobe vessels 0.89 (0.86-0.93)
Interstitial edema 0.83 (0.79-0.86)
Emphysema 0.99 (0.95-1.00)
Fibrosis 1.00 (0.99-1.00)
Pleural effusion 0.94 (0.91-0.98)
CI = confidence interval.
349M. Miniati et al. / Thrombosis Research 133 (2014) 345–351
Author's personal copy
our experience, perfusion lung scintigraphy should also be obtained for
it allows detecting multiple segmental or lobar perfusion defects that
are the hallmark of chronic thromboembolic pulmonary hypertension
[24]. This is amenable of surgical repair if the organized clots are located
in the proximal branches of the pulmonary circulation [1,2,8,10].
Conversely, if the chest radiograph does not meet the criteria for PH,
it is unlikely that the disease be present. We acknowledge, however,
that PH may be misdiagnosed on chest radiography if extensive lung
fibrosis is present. In this connection, a recent study showed that even
computed tomography is unable to reliably predict PH in the presence
of diffuse interstitial lung disease [25].
Some early studies, published long before the introduction of echo-
cardiography, showed thatmeasuring thewidth of themain pulmonary
artery, as percentage of the width of left hemithorax (MPA/LH ratio),
provides a crude but clinically valuable estimation of MPAP [18–20].
Such studies focused on the evaluation of patients with pure mitral
stenosis.
We found a statistically significant curvilinear correlation between
MPA/LH ratio and MPAP measured at RHC in both patients with PH
and those with chronic LHF. The shape of the curve is in all similar to
that described by Moore et al. [18] and Milne [19] in isolated mitral
stenosis, and closely resembles the relationship between pulmonary
distending pressure and pulmonary blood volume in humans receiving
dextran infusion and subsequent atropine injection [26]. Thus, the
normalized width of the main pulmonary artery can be regarded as an
index of pulmonary vascular distensibility in response to an elevation
of MPAP.
As shown in Fig. 5, the curve fitting the data in chronic LHF is steeper
than in PH suggesting a greater pulmonary vascular stiffness in the
former group. This is plausible because long-standing LHF brings about
extensive remodeling of both pulmonary arteries and veins [27].
It should be considered, however, that thewidth of themain pulmo-
nary artery cannot be precisely measured on chest radiography. So,
further investigation seemswarranted by comparing hemodynamically
determined MPAP against the actual width of this vascular segment as
assessed with multidetector computed tomography or magnetic reso-
nance imaging of the heart.
Study Limitations
First, the sample of pulmonary hypertensive patients is relatively
small, and originates from a single referral center. So, it would be desir-
able to confirm our results in a larger sample of patients from different
centers worldwide. Second, we obtained RHC in only 165 (29%) of the
562 subjects included in the study. Yet, none of the 397 individuals,
Fig. 5. Scatter plot of main pulmonary artery (MPA) width, as percentage of width of left hemithorax (LH), against mean pulmonary artery pressure (MPAP) measured at right heart
catheterization in 26 patients with normal pulmonary artery pressure (blue dots), 82 with pre-capillary pulmonary hypertension (red dots), and 57 with chronic left heart failure and
pulmonary venous hypertension (green dots). Panel A: y = 6.507 e(0.0518x) Panel B: y = 4.013 e(0.0767x).
Fig. 4. Relationship between pre-test (clinical) probability and post-test probability of
pulmonary hypertension (PH) conditioned by the results of chest radiography (CXR). We
assumed pre-test probability as based on clinical symptoms and signs only.
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who served as controls, developed PH over a median follow-up time of
about 10 years.
Conclusions
In sum, chest radiography is accurate in predicting PH. It may assist
clinicians in selecting patients with suspected PH for hemodynamic
ascertainment.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.thromres.2013.12.019.
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Appendix A. Analysis of Chest Radiographs
Themain pulmonary arterywas evaluated in the postero-anterior
view. It was considered prominent if convex in shape and bulging
out along the left cardiac border between the aortic knob and the
left atrial appendage [6–10].
Right ventricular enlargement was assessed in the lateral view,
and was rated present if the length of the cardiac border in contact
with the anterior chest wall was greater than one-half the vertical
distance between the cardiophrenic sulcus and the angle of Louis
[6–10]. Left ventricular enlargement was recorded if both of the
following criteria were met: (a) increase in the length of the left
ventricle with leftward and downward displacement of the cardiac
apex (postero-anterior view), and (b) increased convexity of the
posterior aspect of the left ventricle which makes it intersecting
the right hemi-diaphragm behind the edge of the inferior vena cava
at its entry in the thoracic cavity (lateral view).
The pulmonary vessels were evaluated only in the postero-
anterior view. The right descending pulmonary artery was consid-
ered enlarged if the transverse diameter exceeded the upper normal
limit of 16 mm [16]. Vascular pruning was recorded if there was an
abrupt tapering of the distal pulmonary vessels with loss of side
branches [6–10]. Symmetric dilatation of the arteries and veins of the
upper lobes with reduction in caliber of the lower lobe vessels was
recorded as “dilated upper lobe vessels”. This indicates redistribution
of pulmonary blood flow to non-dependent lung regions, and it is
often seen in patients with chronic LHF, or left heart valvular disease
[18–20].
Finally, the raters were asked to look for radiologic abnormalities
such as interstitial edema, emphysema, fibrosis, and pleural effusion.
In the postero-anterior view, the width of the main pulmonary
artery was estimated by measuring the linear distance between the
outermost border of the vessel and the midline of the chest
[18–20]. When the main pulmonary artery was straight or slightly
concave, the measurement was made from a point of its border mid-
way between the aortic knob and the left atrial appendage [18–20].
The width of the main pulmonary artery (MPA) was expressed as
percentage of the width of the left hemithorax (LH) [18–20]. Mea-
surements were taken independently by two raters who were
blinded to hemodynamic data, and the average MPA/LH ratio was
calculated. The latter was compared with MPAP measured at RHC
in 165 patients.
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